Caplight Logo









Delta Pharma

Delta Pharma

Private
CairoHealthcare & Life Scienceshttp://www.deltapharma.eg/site/

Last Round

Private Equity

Oct 11, 2012

Company Overview

Delta Pharma is a pharmaceutical company that manufactures and markets a diverse range of high-quality generic pharmaceutical products in the MENA region.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Pharma Supply Chain

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

branded generic medicinespharmaceutical manufacturinggeneric drugsanimal healthveterinary pharmaceuticalsdrug manufacturingpharmaceutical exportspharma companyMENA pharmaceutical marketfinished dosage formsdietary supplements

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Delta Pharma Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Delta Pharma Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Private EquityOct 11, 2012
View all Funding Rounds

Key People

Founding team and executive leadership

Martina Magdy

PR Senior Specialist Assitant CEO Office Manager, Senior Event Supervisor

Executive Team

Rami Tawfik

Chief Financial Officer

Executive Team

Delta Pharma Investors

Notable investors and investment history

InvestorRounds
Al Imtiaz Investment GroupPrivate Equity
View all Investors

Delta Pharma Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Delta Pharma Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Delta Pharma's valuation, stock price, and market status.

Firmographic Details

HeadquartersCairo
Employee Range748
Year Founded1997
Last FundingOct 11, 2012

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.